Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Contribution of APOA5, APOC3, CETP, ABCA1 and SIK3 genetic variants to hypertriglyceridemia development in Mexican HIV-patients receiving antiretroviral therapy.
Bautista-Martínez JS, Mata-Marín JA, Sandoval-Ramírez JL, Chaparro-Sánchez A, Manjarrez-Téllez B, Uribe-Noguez LA, Gaytán-Martínez J, Núñez-Armendáriz M, Cruz-Sánchez A, Núñez-Rodríguez N, Iván MA, Morales-González GS, Álvarez-Mendoza JP, Pérez-Barragán E, Ríos-De Los Ríos J, Contreras-Chávez GG, Tapia-Magallanes DM, Ribas-Aparicio RM, Díaz-López M, Olivares-Labastida A, Gómez-Delgado A, Torres J, Miranda-Duarte A, Zenteno JC, Pompa-Mera EN. Bautista-Martínez JS, et al. Among authors: nunez rodriguez n. Pharmacogenet Genomics. 2022 Apr 1;32(3):101-110. doi: 10.1097/FPC.0000000000000458. Pharmacogenet Genomics. 2022. PMID: 34693928
Effectiveness and Risk Factors for Virological Outcome of Raltegravir-Based Therapy for Treatment-Experienced HIV-Infected Patients.
Mata-Marín JA, Smeke AE, Rodriguez MR, Chávez-García M, Banda-Lara MI, Rios AM, Nuñez-Rodríguez N, Domínguez-Hermosillo JC, Sánchez AC, Juarez-Kasusky I, Herrera JE, Ramírez JL, Gaytán-Martínez J. Mata-Marín JA, et al. Among authors: nunez rodriguez n. Drugs R D. 2017 Mar;17(1):225-231. doi: 10.1007/s40268-017-0174-z. Drugs R D. 2017. PMID: 28124232 Free PMC article.
Effectiveness of tipranavir versus darunavir as a salvage therapy in HIV-1 treatment-experienced patients.
Domínguez-Hermosillo JC, Mata-Marin JA, Herrera-González NE, Chávez-García M, Huerta-García G, Nuñez-Rodríguez N, García-Gámez JG, Jiménez-Romero A, Gaytán-Martínez JE. Domínguez-Hermosillo JC, et al. Among authors: nunez rodriguez n. J Infect Dev Ctries. 2016 Sep 30;10(9):982-987. doi: 10.3855/jidc.6629. J Infect Dev Ctries. 2016. PMID: 27694731 Free article.
Effectiveness of etravirine-based therapy for treatment-experienced HIV-infected patients.
Huerta García G, Mata-Marín JA, Domínguez-Hermosillo JC, Chavez-García M, Banda-Lara MI, Nuñez-Rodríguez N, Cruz-Herrera JE, Sandoval-Ramírez JL, Villagómez-Ruiz A, Manjarrez-Tellez B, Gaytan-Martínez JE. Huerta García G, et al. Among authors: nunez rodriguez n. J Infect Dev Ctries. 2016 Jun 30;10(6):605-11. doi: 10.3855/jidc.7512. J Infect Dev Ctries. 2016. PMID: 27367009 Free article.
Effectiveness and risk factors for virological outcome of darunavir-based therapy for treatment-experienced HIV-infected patients.
Mata-Marín JA, Huerta-García G, Domínguez-Hermosillo JC, Chavez-García M, Banda-Lara MI, Nuñez-Rodríguez N, Cruz-Herrera JE, Sandoval-Ramírez JL, Martínez-Abarca I, Villagómez-Ruíz AF, Manjarrez-Tellez B, Gaytán-Martínez J. Mata-Marín JA, et al. Among authors: nunez rodriguez n. AIDS Res Ther. 2015 Sep 24;12:31. doi: 10.1186/s12981-015-0072-9. eCollection 2015. AIDS Res Ther. 2015. PMID: 26413132 Free PMC article.